Phase II study of dasatinib in combination with cetuximab in recurrent/metastatic head and neck squamous cell carcinoma

被引：1
|
作者：
Stabile, Laura P.
Egloff, Ann Marie
Zhou, Pei
Gooding, William E.
Grandis, Jennifer R.
Bauman, Julie E.
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-CT119
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT119
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Phase II study of pemetrexed in combination with cisplatin and cetuximab in recurrent or metastatic squamous cell carcinoma of the head and neck
    Vermorken, J. B.
    Licitra, L.
    Stoehlmacher-Williams, J.
    Dietz, A.
    Lopez-Picazo, J. M.
    Hamid, O.
    Hossain, A. M.
    Chang, S. -C.
    Gauler, T. C.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 (13) : 2877 - 2883
  • [2] Phase II study of cetuximab and lenalidomide in recurrent/metastatic squamous cell carcinoma of the head and neck.
    Taylor, Rodney J.
    Saloura, Vassiliki
    Wong, Richard
    Goloubeva, Olga
    Silpino, Lorna
    de Souza, Jonas
    Seiwert, Tanguy
    Vokes, Everett
    Cohen, Ezra
    Villaflor, Victoria
    [J]. MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [3] A randomized, phase II study of afatinib versus cetuximab in metastatic or recurrent squamous cell carcinoma of the head and neck
    Seiwert, T. Y.
    Fayette, J.
    Cupissol, D.
    del Campo, J. M.
    Clement, P. M.
    Hitt, R.
    Degardin, M.
    Zhang, W.
    Blackman, A.
    Ehrnrooth, E.
    Cohen, E. E. W.
    [J]. ANNALS OF ONCOLOGY, 2014, 25 (09) : 1813 - 1820
  • [4] Phase I/II study of cetuximab in combination with cisplatin or carboplatin and fluorouracil in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
    Bourhis, Jean
    Rivera, Fernando
    Mesia, Ricard
    Awada, Ahmad
    Geoffrois, Lionel
    Borel, Christian
    Humblet, Yves
    Lopez-Pousa, Antonio
    Hitt, Ricardo
    Vega Villegas, M. Eugenia
    Duck, Lionel
    Rosine, Dominique
    Amellal, Nadia
    Schueler, Armin
    Harstrick, Andreas
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 2866 - 2872
  • [5] Phase 1 and Pharmacokinetic Study of Everolimus in Combination With Cetuximab and Carboplatin for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
    Saba, Nabil F.
    Hurwitz, Selwyn J.
    Magliocca, Kelly
    Kim, Sungjin
    Owonikoko, Taofeek K.
    Harvey, Donald
    Ramalingam, Suresh S.
    Chen, Zhengjia
    Rogerio, Jackie
    Mendel, Jennifer
    Kono, Scott A.
    Lewis, Colleen
    Chen, Amy Y.
    Higgins, Kristin
    El-Deiry, Mark
    Wadsworth, Trad
    Beitler, Jonathan J.
    Shin, Dong M.
    Sun, Shi-Yong
    Khuri, Fadlo R.
    [J]. CANCER, 2014, 120 (24) : 3940 - 3951
  • [6] Interim analysis of the combination of durvalumab and cetuximab in a phase II trial of patients with recurrent and metastatic head and neck squamous cell carcinoma
    Gulati, Shuchi
    Palackdharry, Sarah
    Weatherford, Layne
    Wilson, Sarah
    Desai, Shireen
    Steele, Aubrey
    Riaz, Kashif
    Takiar, Vinita
    Draper, Trisha
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [7] Phase II Study of Cetuximab and Lenalidomide in Recurren/metastatic Squamous Cell Carcinoma of the Head and Neck
    Taylor, R.
    Wong, S.
    Chan, A.
    Silipino, L.
    Villaflor, V.
    Vokes, E.
    de Souza, J.
    Seiwert, T.
    Cohen, E.
    [J]. EUROPEAN JOURNAL OF CANCER, 2012, 48 : 100 - 100
  • [8] Cetuximab for the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck
    Greenhalgh, J.
    Bagust, A.
    Boland, A.
    Fleeman, N.
    McLeod, C.
    Dundar, Y.
    Proudlove, C.
    Shaw, R.
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2009, 13 : 49 - 54
  • [9] Simlukafusp a and cetuximab combination in patients with recurrent, unresectable or metastatic squamous cell carcinoma of the head and neck
    Hansen, A. R.
    Gomez-Roca, C. A.
    Lolkema, M. P.
    Verlingue, L.
    Italiano, A.
    Spicer, J.
    Steeghs, N.
    Bauman, J. E.
    Fayette, J.
    Niu, J.
    Prenen, H.
    Dejardin, D.
    Boetsch, C.
    Kraxner, A.
    Evers, S.
    Vardar, T.
    Keshelava, N.
    Teichgraber, V.
    Bonomi, M.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S805 - S805
  • [10] Phase II study of ispinesib in recurrent or metastatic squamous cell carcinoma of the head and neck
    Tang, Patricia A.
    Siu, Lillian L.
    Chen, Eric X.
    Hotte, Sebastien J.
    Chia, Stephen
    Schwarz, James K.
    Pond, Gregory R.
    Johnson, Caitlin
    Colevas, A. Dimitrios
    Synold, Timothy W.
    Vasist, Lakshmi S.
    Winquist, Eric
    [J]. INVESTIGATIONAL NEW DRUGS, 2008, 26 (03) : 257 - 264
12345